Incyte | セールス

Sales 変化する 日付
Acadia Pharmaceuticals USD 231.04M 19.34M 2023-12
Agenus USD 83.8M 59.49M 2023-12
Agios Pharmaceuticals USD 7.1M 296K 2023-12
Alnylam Pharmaceuticals USD 439.72M 310.81M 2023-12
Amgen USD 8.2B 1.29B 2023-12
BioCryst Pharmaceuticals USD 93.4M 6.66M 2023-12
Biogen USD 2.39B 144M 2023-12
BioMarin Pharmaceutical USD 646.21M 64.88M 2023-12
Bluebird Bio USD 12.39M 5.5M 2023-09
Bristol-Myers Squibb USD 11.48B 511M 2023-12
Eli Lilly USD 9.35B 145.2M 2023-12
Exelixis USD 479.65M 7.73M 2023-12
Gilead Sciences USD 7.12B 64M 2023-12
Incyte USD 1.01B 94.32M 2023-12
Ionis Pharmaceuticals USD 325M 180.79M 2023-12
Lumos Pharma USD 826K 819K 2023-12
MacroGenics USD 10.72M 323K 2023-12
Merck USD 14.63B 1.33B 2023-12
Moderna USD 2.81B 980M 2023-12
Nektar Therapeutics USD 23.88M 259K 2023-12
Neurocrine Biosciences USD 515.2M 16.4M 2023-12
Novartis USD 11.78B 316M 2023-12
Novartis USD 11.78B 316M 2023-12
Pfizer USD 14.25B 1.02B 2023-12
PTC Therapeutics USD 307.06M 110.48M 2023-12
Puma Biotechnology USD 72.18M 16.06M 2023-12
Regeneron Pharmaceuticals USD 3.43B 71.6M 2023-12
Sarepta Therapeutics USD 396.78M 64.96M 2023-12
Ultragenyx Pharmaceutical USD 127.39M 29.34M 2023-12
Vertex Pharmaceuticals USD 2.52B 34.2M 2023-12



Incyte セールス - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.